Benzinga | Nov 2, 2021 04:53PM EDT

Rigel Pharmaceuticals Q3 EPS $(0.12) Misses $(0.10) Estimate, Sales $21.54M Miss $23.56M Estimate

Rigel Pharmaceuticals (NASDAQ:RIGL) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent. This is a 50 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $21.54 million which missed the analyst consensus estimate of $23.56 million by 8.56 percent. This is a 17.15 percent increase over sales of $18.39 million the same period last year.